Effect of Losartan on Left Ventricular Diastolic Function in Patients With Nonobstructive Hypertrophic Cardiomyopathy
- 1 December 2005
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 96 (11), 1563-1567
- https://doi.org/10.1016/j.amjcard.2005.07.065
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive PatientsCirculation, 2002
- Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic CardiomyopathyCirculation, 2001
- Effects of losartan on the collagen degradative enzymes in hypertrophic and congestive types of cardiomyopathic hamsters.Molecular and Cellular Biochemistry, 2001
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 2000
- Angiotensin II Has Multiple Profibrotic Effects in Human Cardiac FibroblastsCirculation, 2000
- Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential HypertensionCirculation, 1998
- Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiographyJournal of the American Society of Echocardiography, 1996
- Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failureJournal of the American College of Cardiology, 1995
- Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.Circulation, 1994
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978